Filtros de búsqueda

Lista de obras de Francesca Romana Mauro

5'-Azacitidine for therapy-related myelodysplastic syndromes after non-Hodgkin lymphoma treatment

scientific article published on 15 June 2011

A case of concomitant chronic lymphocytic leukaemia and hairy cell leukaemia evaluated for IGHV-D-J rearrangements and BRAF-V600E mutation: lack of evidence for a common origin.

artículo científico publicado en 2015

A gender-based score system predicts the clinical outcome of patients with early B-cell chronic lymphocytic leukemia

artículo científico publicado en 2005

A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemia

artículo científico publicado en 2007

A high-density SNP genomewide linkage scan for chronic lymphocytic leukemia-susceptibility loci

artículo científico publicado en 2005

A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients.

artículo científico publicado en 2015

A subset of chronic lymphocytic leukemia patients display reduced levels of PARP1 expression coupled with a defective irradiation-induced apoptosis.

artículo científico publicado en 2011

ATM gene alterations in chronic lymphocytic leukemia patients induce a distinct gene expression profile and predict disease progression

artículo científico publicado en 2011

Acute leukaemia in patients treated for Hodgkin's disease.

artículo científico publicado en 1984

Adhesion Molecule Expression on B-Cells from Acute and Chronic Lymphoid Leukemias ⬇️

artículo científico publicado el 1 de diciembre de 1994

An Increased Number of Individuals with Clinically Recognized Monoclonal B-Cell Lymphocytosis Characterizes a Recent Database of Chronic Lymphocytic Leukemia Rai Stage 0

artículo científico publicado en 2012

An Italian retrospective study on the routine clinical use of low-dose alemtuzumab in relapsed/refractory chronic lymphocytic leukaemia patients

scientific article published on 09 December 2011

Another treatment option for relapsed or refractory chronic lymphocytic leukaemia

artículo científico publicado en 2017

Appropriate use of bendamustine in first-line therapy of chronic lymphocytic leukemia. Recommendations from SIE, SIES, GITMO Group.

artículo científico publicado en 2014

Autoimmune hemolytic anemia during bendamustine plus rituximab treatment in CLL patients: multicenter experience

artículo científico publicado en 2016

B-cell receptor configuration and adverse cytogenetics are associated with autoimmune hemolytic anemia in chronic lymphocytic leukemia

artículo científico publicado en 2012

BCR ligation induced by IgM stimulation results in gene expression and functional changes only in IgV H unmutated chronic lymphocytic leukemia (CLL) cells.

artículo científico publicado en 2008

Behind the scenes of non-nodal MCL: downmodulation of genes involved in actin cytoskeleton organization, cell projection, cell adhesion, tumour invasion, TP53 pathway and mutated status of immunoglobulin heavy chain genes

scientific article published on 08 December 2011

Bendamustine in combination with ofatumumab in relapsed or refractory chronic lymphocytic leukemia: a GIMEMA Multicenter Phase II Trial.

artículo científico publicado en 2013

Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments

artículo científico publicado en 2015

Biallelic BIRC3 inactivation in chronic lymphocytic leukaemia patients with 11q deletion identifies a subgroup with very aggressive disease

artículo científico publicado en 2018

Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft-versus-leukaemia effect.

artículo científico publicado en 1988

Bullous lesions in chronic lymphocytic leukaemia: pemphigoid or insect bites?

artículo científico publicado en 2006

CD4(+)CD45RA(+)CXCR4 (+) lymphocytes are inversely associated with progression in stages I-III melanoma patients.

artículo científico publicado en 2009

Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: correlation with biologically-based risk stratification

artículo científico publicado en 2017

Chlorambucil plus rituximab with or without maintenance rituximab as first-line treatment for elderly chronic lymphocytic leukemia patients.

artículo científico publicado en 2014

Chromosome 2p gain in monoclonal B-cell lymphocytosis and in early stage chronic lymphocytic leukemia.

artículo científico publicado en 2012

Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features

artículo científico publicado en 2003

Clinical categories identified by a new prognostic index reflect biological characteristics of patients in early chronic lymphocytic leukemia: The Gruppo Italiano Studio Linfomi (GISL) experience

artículo científico publicado en 2010

Clinical characteristics and outcome of patients with autoimmune hemolytic anemia uniformly defined as primary by a diagnostic work-up

artículo científico publicado en 2016

Clinical relevance of hypogammaglobulinemia, clinical and biologic variables on the infection risk and outcome of patients with stage A chronic lymphocytic leukemia

artículo científico publicado en 2017

Clinical relevance of silent red blood cell autoantibodies

artículo científico publicado en 2017

Combination of Cytosine-Arabinoside (ARA-C), Cyclophosphamide and Prednisone in the Treatment of B-Chronic Lymphocytic Leukemia in Advanced Stages and Progressive Disease.

artículo científico publicado en 1991

Combination of bendamustine and rituximab as front-line therapy for patients with chronic lymphocytic leukaemia: multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials.

artículo científico publicado en 2016

Comparison between the CLL-IPI and the Barcelona-Brno prognostic model: Analysis of 1299 newly diagnosed cases.

artículo científico publicado en 2017

Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease.

artículo científico publicado en 2015

Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: on behalf of the GIMEMA chronic lymphoproliferative diseases working group

artículo científico publicado en 2010

Disappearance of Bone Marrow Fibrosis in a Patient with Chronic Myeloid Leukemia Treated with Dasatinib.

artículo científico publicado en 2017

Early CD49d downmodulation in chronic lymphocytic leukemia patients treated front-line with ibrutinib plus rituximab predicts long-term response

artículo científico publicado en 2022

Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study

scientific article published on 24 September 2020

Enteral nutrition may cause false-positive results of Aspergillus galactomannan assay in absence of gastrointestinal diseases

artículo científico publicado en 2011

Evaluation of TP53 mutations with the AmpliChip p53 research test in chronic lymphocytic leukemia: correlation with clinical outcome and gene expression profiling.

artículo científico publicado en 2011

Evidence of biased immunoglobulin variable gene usage in highly stable B-cell chronic lymphocytic leukemia.

artículo científico publicado en 2004

Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma

artículo científico publicado en 2017

Familial cancer associated with a polymorphism in ARLTS1

artículo científico publicado en 2005

Fludarabine plus alemtuzumab (FA) front-line treatment in young patients with chronic lymphocytic leukemia (CLL) and an adverse biologic profile.

artículo científico publicado en 2013

Fludarabine, cyclophosphamide and lenalidomide in patients with relapsed/refractory chronic lymphocytic leukemia. A multicenter phase I-II GIMEMA trial.

artículo científico publicado en 2016

Gene expression profile of protein kinases reveals a distinctive signature in chronic lymphocytic leukemia and in vitro experiments support a role of second generation protein kinase inhibitors.

artículo científico publicado en 2009

Gene mutations in lenalidomide-treated CLL

artículo científico publicado en 2018

High occurence of DRB1 11 in chronic lymphocytic leukaemia families

artículo científico publicado en 2002

IL4 production and increased CD30 expression by a unique CD8+ T-cell subset in B-cell chronic lymphocytic leukaemia

scientific article published on 01 March 1999

Identification of monoclonal B-cell lymphocytosis among sibling transplant donors for chronic lymphocytic leukemia patients

artículo científico publicado en 2009

IgD cross-linking induces gene expression profiling changes and enhances apoptosis in chronic lymphocytic leukemia cells.

artículo científico publicado en 2013

Immunoglobulin heavy chain variable region gene and prediction of time to first treatment in patients with chronic lymphocytic leukemia: Mutational load or mutational status? Analysis of 1003 cases

scientific article published on 30 July 2018

In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics.

artículo científico publicado en 2018

Increased chronic lymphocytic leukemia proliferation upon IgM stimulation is sustained by the upregulation of miR-132 and miR-212.

artículo científico publicado en 2015

Increased serum BAFF (B-cell activating factor of the TNF family) level is a peculiar feature associated with familial chronic lymphocytic leukemia

artículo científico publicado en 2008

Insight into the pathogenesis of chronic lymphocytic leukemia (CLL) through analysis of IgVH gene usage and mutation status in familial CLL

article

Inter- and intra-patient clonal and subclonal heterogeneity of chronic lymphocytic leukaemia: evidences from circulating and lymph nodal compartments.

artículo científico publicado en 2015

Is the aberrant expression of p53 by immunocytochemistry a surrogate marker of TP53 mutation and/or deletion in chronic lymphocytic leukemia?

scientific article published on 01 January 2011

Italian external and multicentric validation of the MD Anderson Cancer Center nomogram and prognostic index for chronic lymphocytic leukaemia patients: analysis of 1502 cases

artículo científico publicado en 2014

Late listeriosis after fludarabine plus prednisone treatment.

artículo científico publicado en 1994

Linkage analysis for ATM in familial B cell chronic lymphocytic leukaemia

artículo científico publicado en 1999

Longitudinal analysis of human herpesvirus-8 DNA and antibodies in an Italian allogeneic stem cell transplant recipient.

artículo científico publicado en 2011

Management of elderly and unfit patients with chronic lymphocytic leukemia

artículo científico publicado en 2016

Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia

artículo científico publicado en 2015

NOTCH1, SF3B1, BIRC3 and TP53 mutations in patients with chronic lymphocytic leukemia undergoing first-line treatment: correlation with biological parameters and response to treatment.

artículo científico publicado en 2014

Proliferative responses to PHA, anti-CD3 and antigens in patients with lymphoproliferative disease of granular lymphocytes. Mannoproteins of Candida albicans induce proliferation and cytotoxicity.

artículo científico publicado en 1997

Prospective validation of predictive value of abdominal computed tomography scan on time to first treatment in Rai 0 chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study

artículo científico publicado en 2015

Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations

artículo científico publicado en 2020

Reduced susceptibility to apoptosis correlates with kinetic quiescence in disease progression of chronic lymphocytic leukaemia

artículo científico publicado en 2001

SIE, SIES, GITMO updated clinical recommendations for the management of chronic lymphocytic leukemia

artículo científico publicado en 2011

Severe autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia responsive to fludarabine-based treatment

artículo científico publicado en 1992

Spontaneous regression of chronic lymphocytic leukemia: clinical and biologic features of 9 cases.

artículo científico publicado en 2009

Standard conditioning regimen and T-depleted donor bone marrow for transplantation in chronic myeloid leukemia

artículo científico publicado en 1986

Stereotyped subset #1 chronic lymphocytic leukemia: a direct link between B-cell receptor structure, function, and patients' prognosis.

artículo científico publicado en 2014

The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: A retrospective multicentric GIMEMA experience

article

The prognostic value of CD38 expression in chronic lymphocytic leukaemia patients studied prospectively at diagnosis: a single institute experience.

artículo científico publicado en 2005

The utility of a prognostic index for predicting time to first treatment in early chronic lymphocytic leukemia: the GIMEMA experience

artículo científico publicado en 2009

Total body computed tomography scan in the initial work-up of Binet stage A chronic lymphocytic leukemia patients: Results of the prospective, multicenter O-CLL1-GISL study

artículo científico publicado en 2013

Treatment of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD).

artículo científico publicado en 1982

Unravelling the suboptimal response of TP53-mutated chronic lymphocytic leukaemia to ibrutinib

artículo científico publicado en 2018

Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients.

artículo científico publicado en 2016

Venetoclax in CLL patients who progress after B-cell Receptor inhibitor treatment: a retrospective multi-centre Italian experience

artículo científico publicado en 2019

Venetoclax: a chance for patients with chronic lymphocytic leukaemia previously treated with ibrutinib

artículo científico publicado en 2017

White blood cell count at diagnosis and immunoglobulin variable region gene mutations are independent predictors of treatment-free survival in young patients with stage A chronic lymphocytic leukemia ⬇️

artículo científico publicado el 29 de diciembre de 2010

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda